Modulation of human lepromatous monocyte-macrophage functions in vitro by tuftsin.
Human peripheral blood monocytes/macrophages derived from normal donors, patients of tuberculoid leprosy (BT/TT) and lepromatous leprosy (BL/LL) were assayed for stimulated phagocytic responses to the potent macrophage stimulator "Tuftsin" (NH2-Thr-Lys-Pro-Arg-OH) after varying periods (6 h to 14 days) of culture in vitro. The assays consisted of visual scoring of ingested Mycobacterium leprae and radiometric measurement of ingested 14C-acetate labelled Staphylococcus aureus and Mycobacterium tuberculosis (H37Ra). While normal and BT/TT macrophages showed a progressively increasing ability for tuftsin-stimulated phagocytosis with increasing age of culture in vitro, BL/LL macrophages showed the opposite response so that 14-day cultures were refractory to a stimulatory dose of up to 7.0 microM (10 to 20 times the optimal dose for normal and BT/TT macrophages). The 14-day BL/LL macrophage cultures were, however, responsive to 35 microM tuftsin (100 times the optimal dose for normal macrophages). Analysis of the dose-response curves also indicates that BT/TT cultures despite exhibiting an apparent similarity to normal macrophages demonstrate a rightward shift for a maximal stimulated phagocytosis. Finally SEM photo-micrographs of 14-day macrophage cultures of the three groups revealed that while normal and BT/TT cultures demonstrated an increase in membrane ruffling and filopodia on stimulation with 0.8 microM tuftsin, BL/LL cultures exhibited none of the features associated with stimulation. From the above findings, we conclude that lepromatous macrophages may display an aberrant differentiation profile leading to a terminal state of unresponsiveness and that the defect may possibly lie at the level of tuftsin receptor expression or transmembrane signal transduction.
Iyer
R R
RR
Department of Biochemistry, All India Institute of Medical Sciences, New Delhi.
Prasad
H K
HK
Bhutani
L K
LK
Rao
D N
DN
D000595:Amino Acid Sequence; D001419:Bacteria / Q000276:immunology; D001770:Blood Bactericidal Activity / Q000276:immunology; D006801:Humans; D066298:In Vitro Techniques; D007918:Leprosy / Q000276:immunology*; D015440:Leprosy, Lepromatous / Q000097:blood / Q000276:immunology; D015441:Leprosy, Tuberculoid / Q000097:blood / Q000276:immunology; D008264:Macrophages / Q000276:immunology; D008969:Molecular Sequence Data; D009000:Monocytes / Q000276:immunology; D010586:Phagocytes / Q000276:immunology*; D010587:Phagocytosis; D014405:Tuftsin / Q000737:chemistry / Q000494:pharmacology*
D014405:Tuftsin